UK tribunal's hydrocortisone case findings weren’t flawed, appeal court says
MLex Summary: The UK's competition court didn’t err when it upheld key findings from the antitrust watchdog over competition breaches in relation to the supply of hydrocortisone tablets, UK appeal judges have...To view the full article, register now.
Already a subscriber? Click here to view full article